Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers reported at a conference in Vienna.

Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers reported at a conference in Vienna.

A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, a clinical trial found.